Evonik receives Asia-Pacific Bioprocessing Excellence Award second year in a row
The company received the award for its Cell Culture Solutions portfolio in the category Best New Bioprocessing Supplier Award: Upstream Processing. ... MORE
Find the latest news from our company.
The company received the award for its Cell Culture Solutions portfolio in the category Best New Bioprocessing Supplier Award: Upstream Processing. ... MORE
EUDRAGIT® polymers have been used as coatings to create more effective drugs for 70 years. Over the decades, the portfolio of methacrylate polymers has established itself as the industry standard. ... MORE
Evonik and the University of Mainz have signed a license agreement to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs. ... MORE
Evonik’s non-animal-derived squalene PhytoSquene® is now available produced under GMP. PhytoSquene® is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. ... MORE
EUDRACAP® preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. ... MORE
Evonik is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology. ... MORE